ResearchLong-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy.
Jan 18, 2025Journal ArticleAdjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma.Written by 1 Roon author & 28 others Via Annals of Surgical Oncology
ResearchDelta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms.
ResearchLoss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial Radioembolization.
ResearchDelta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.
ResearchSafety and efficacy of Yttrium-90 transarterial radioembolization of neuroendocrine liver metastasis - A retrospective single-institution study.
ResearchLong-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy
Jan 18, 2025Journal ArticleAdjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic Cholangiocarcinoma.Written by 1 Roon author & 28 others Via Annals of Surgical Oncology
ResearchDelta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms
ResearchLoss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial Radioembolization
ResearchTreatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study.